# Future Directions and Recommendations

## Current Trends and Future Directions

### Multi-Omics Foundation Models

An emerging trend is integrating multiple data modalities ([Wu et al., 2024, arXiv](https://arxiv.org/pdf/2512.14019)):

**Beyond Sequence Alone**
- Combining DNA sequence with epigenetic marks
- Integrating gene expression, protein abundance, metabolomics
- Incorporating chromatin accessibility and 3D structure
- Linking sequence to cellular phenotypes

**Potential Advantages**
- Richer representations of biological state
- Better prediction of complex phenotypes
- More comprehensive understanding of regulation
- Alignment with systems biology perspective

**Technical Challenges**
- Different modalities have different scales and distributions
- Missing data is common across modalities
- Computational requirements multiply
- Interpretation becomes more complex

**Examples**
- Models combining scRNA-seq with scATAC-seq
- Integration of sequence with chromatin conformation data
- Multi-modal cell state representations

### Cell-State Foundation Models

Rather than pure sequence models, focus on cellular representation:
- scRNA-seq based models (scGPT, Geneformer, scBERT)
- Learning from perturbation data (e.g., Perturb-seq)
- Predicting cellular responses to genetic/chemical perturbations
- Drug discovery and cell engineering applications

### More Realistic Evaluation

The field is moving toward:
- Standardized benchmarks with diverse tasks
- Rigorous comparison with simple baselines
- Transparent reporting of limitations
- Focus on practical utility over novelty
- Better understanding of when foundation models actually help
- Cost-benefit analysis including computational requirements

### Architectural Innovations

Beyond standard transformers:
- State space models (e.g., Mamba, Hyena) for longer contexts
- Sparse attention mechanisms
- Hierarchical architectures for multi-scale genomics
- Graph neural networks for 3D genome structure
- Hybrid models combining multiple approaches

### Open Questions

**Scientific Questions**
- What genomic patterns do these models actually learn?
- Are emergent properties real or measurement artifacts?
- How can we make models more interpretable?
- What's the minimal data needed for useful foundation models?
- Do models capture causal relationships or just correlations?

**Practical Questions**
- When should practitioners use foundation models vs. traditional methods?
- How to make these models accessible beyond large research groups?
- What compute requirements are justified by performance gains?
- How to ensure reproducibility and reliability?
- How to handle model versioning and updates?

**Ethical and Policy Questions**
- How to ensure equitable access to powerful genomic AI tools?
- Privacy concerns with genomic data in foundation models
- Potential misuse in synthetic biology applications
- Intellectual property and commercialization issues

## Key Takeaways

1. **Foundation models in genomics are promising but overhyped**: The theoretical potential is real, but current implementations often underdeliver relative to claims.

2. **Simple baselines are surprisingly strong**: Before deploying complex foundation models, validate that they outperform straightforward alternatives like linear models with k-mer features.

3. **Evaluation matters critically**: Claims should be backed by rigorous, standardized evaluation against appropriate baselines. Be skeptical of papers lacking comprehensive benchmarking or comparing only to weak baselines.

4. **Context is crucial**: "Genomics foundation model" can mean very different things. Understand the training data, architecture, intended use cases, and actual performance before adoption.

5. **The field is maturing**: Moving from hype to rigorous science, with better benchmarks and more honest assessment of limitations. Recent publications show increased methodological rigor.

6. **Look beyond sequence**: Multi-omics and cell-state models may ultimately prove more valuable than pure sequence models for many biological applications.

7. **Traditional bioinformatics still valuable**: Foundation models are tools to complement, not replace, existing methods. Domain knowledge and mechanistic understanding remain essential.

8. **Computational costs matter**: The environmental and financial costs of training and deploying foundation models must be justified by tangible performance gains.

9. **Interpretability is often lacking**: Understanding *why* a model makes predictions remains challenging, limiting scientific insight and trust.

10. **Success depends on the task**: Foundation models may excel for some applications while offering no advantage for others. Task-specific evaluation is essential.

## Recommendations for Practitioners

### When to Consider Foundation Models

- You have limited labeled data but access to relevant unlabeled sequence data
- Transfer learning from other species/contexts could be valuable
- Task requires capturing long-range dependencies (>1kb)
- You need embeddings for multiple downstream tasks
- Computational resources are available

### When to Use Simpler Approaches

- Strong baseline methods exist for your task
- Interpretability is critical
- Computational resources are limited
- Training data is abundant for your specific task
- Real-time predictions are needed

### Best Practices

1. **Start with baselines**: Establish performance of simple methods first
2. **Use existing benchmarks**: Compare against standardized tasks
3. **Report honestly**: Include negative results and limitations
4. **Consider costs**: Factor in computational requirements
5. **Validate thoroughly**: Test on held-out data from different sources
6. **Seek interpretability**: Use attention analysis, ablations, probes
7. **Be specific**: Clearly define model capabilities and limitations
8. **Share resources**: Make models and code openly available
9. **Update regularly**: Re-evaluate as new benchmarks emerge
10. **Combine approaches**: Consider ensemble methods with traditional tools

## Conclusion

Foundation models represent an important development in genomics, bringing powerful machine learning approaches to bear on fundamental biological questions. However, the field must move beyond hype to rigorous evaluation and honest assessment of capabilities.

The coming years will likely see continued progress in architecture design, multi-omics integration, and task-specific optimization. Success will require collaboration between machine learning researchers, experimental biologists, and clinicians to ensure models address real biological needs rather than just technical benchmarks.

Most importantly, foundation models should be viewed as one tool among many in the genomics toolkit—powerful when applied appropriately, but not a universal solution. The goal is not to build the biggest model or claim the most revolutionary advance, but to develop practical tools that genuinely advance our understanding of genome biology and improve human health.
